Followers | 52 |
Posts | 10890 |
Boards Moderated | 11 |
Alias Born | 06/25/2009 |
Saturday, August 24, 2019 1:55:27 PM
Published on August 10, 2019
By Joe Lowry
If you are a regular reader of this space you know I have been quite negative on my former employer over the past few years, calling their hydroxide focused strategy “the House of Cards”; saying things like “it is better to be lucky than good” and even referring to Livent’s CEO, Paul Graves as the “chief reader” of the Livent “story”. Sorry Paul.
First, before I continue with my “partial House of Cards mea culpa”, let me clarify some key points in how I think about the former world lithium #2. For most of the years I worked for FMC Lithium, they were committed to being an industry leader. Unfortunately, with the arrival of new CEO in 2010, FMC Corporation focused on becoming a boutique Ag-Chem company and many suboptimal decisions related to the lithium business ensued. You can trace the beginning of FMC Lithium’s slide to #5 to the arrival of CEO Pierre Brondeau and his decidedly “non lithium” agenda. Not making a value judgement just stating the obvious.
While FMC failed to make resource investments in this decade, their western world competitors, SQM and Albemarle, added capacity; as did China powers Ganfeng and Tianqi. The “Big 3” morphed into the “Big 4” with FMC as the “odd one out” dropping to #5 and rapidly losing relevance.
By Q4 2012, I was out of FMC and by early 2013 I was working with a number of companies: Ganfeng, FMC Lithium’s Japanese JV partner, a large Japanese trading company and several juniors. My long tenure in the industry also led to many short term engagements providing my perspective on FMC Lithium – past, present and future. My comments were generally along the lines of: FMC makes great products but the new management doesn’t understand the franchise or the future. The best example of this was when the CEO had the “revelation” to rebrand FMC Lithium as a “minerals” business and lump it in with soda ash. For someone like me who had spent the better part of a career trying to convince the market that FMC Lithium was THE “specialty chemical” lithium producer seeing a clueless CEO confuse the lithium market with the “minerals” re-branding strategy was hard to take despite the fact I was no longer an employee. Loyalties die hard.
The day after I left FMC in 2012, Paul Graves joined the company as Chief Financial Officer. Last year when FMC spun off the Lithium Division, Paul was named the CEO of the new company that took the name Livent. Long before Paul was directly involved in the lithium business, the hydroxide strategy that I christened the “House of Cards” was announced by the now departed lithium leadership team.
Why did I call FMC’s hydroxide strategy the “House of Cards” back in 2016?
Read the rest here.
https://www.linkedin.com/pulse/another-look-livent-joe-lowry/
Recent LTHM News
- Arcadium Lithium Announces Date for Fourth Quarter 2023 Earnings Release and Webcast Conference Call • PR Newswire (US) • 01/23/2024 10:00:00 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/22/2024 12:20:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:10:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:07:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:03:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:00:49 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/04/2024 09:11:03 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 01/04/2024 09:08:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 02:10:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 10:24:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 09:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 09:06:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 10:22:52 PM
- Livent Set to Join S&P MidCap 400; NCR Voyix and Rush Enterprises to Join S&P SmallCap 600 • PR Newswire (US) • 12/19/2023 10:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:21:46 PM
- Livent and Allkem Shareholders Approve Merger of Equals • PR Newswire (US) • 12/19/2023 08:55:00 PM
- Google $700M Antitrust Settlement, TSMC Chairman Retirement, Tesla Nevada Wage Hike, and More • IH Market News • 12/19/2023 11:10:01 AM
- LIVENT INVESTS IN ILiAD TECHNOLOGIES TO STRENGTHEN LEADERSHIP IN DIRECT LITHIUM EXTRACTION PRODUCTION PROCESSES • PR Newswire (US) • 12/14/2023 11:47:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/13/2023 01:41:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 01:07:16 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/11/2023 10:26:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM